Josie has extensive experiences serving global and local biopharmaceutical clients across a broad range of topics in China. She has a focus on R&D, business development and strategic partnership, launch and growth strategy, and commercial model innovation.
Her recent work includes the following:
- assessing IPO readiness and crafting equity story for leading China-originated biotechnology companies
- developing a winning franchise strategy in China
- supporting cross-border business development and strategic partnerships
- designing and building innovative digital-enabled business models and products from omnichannel physician engagement to digitally enabled patient activation and engagement.
Josie is a regular speaker at leading industry conferences in China, and she has authored articles on healthcare innovation and hosted regular executive roundtables for China’s biotech leaders.